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BACKGROUND: While array-comparative genomic hybridization (a-CGH) and next-
generation sequencing (NGS or exome) technologies have swiftly spread throughout
the medical field, karyotype has gradually lost its leading role among genetic tests.
Several international guidelines recommend starting with a-CGH screening then going
on with exome analysis when investigating a patient with intellectual disability (ID)
and no precise clinical diagnosis. A-CGH and whole exome sequencing increase
etiologic diagnoses rate up to 30% in case of ID. However, physicians have to deal with
the lack of qualitative information of the genome. Especially, exome and a-CGH
analysis fail to detect chromosomal rearrangements because breakpoints are either
located in introns or not associated with a gain or loss of genetic material. If these
technologies cannot easily identify chromosomal translocations or inversions which
sometimes split a gene, karyotype can.
DISCUSSION: For the 5 cases described, karyotype provided the right diagnosis for a
Mendelian disease while molecular analysis remained unsuccessful. We conclude that
when a Mendelian disease is strongly suggested clinically, if molecular analysis is
normal, it could be very useful to carry out a karyotype in order to demonstrate a
chromosomal rearrangement involving the targeted gene. If this gene is disrupted, the
physician can confirm the suspected disease and give appropriate genetic counseling.
SUMMARY: This article aims at keeping in mind that karyotype, this old-fashioned
genetic tool, can still remain powerful and useful within some genetic issues. Even in
this modern period of whole exome sequencing, young geneticists should know that
karyotype remains a powerful and cheap technology, available throughout the world
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